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sociated with several days of heavy 
rainfall from typhoons. Therefore, the 
typhoons may be the reason for high 
incidence in October–December.
 The annual incidence of lep-
tospirosis in Taiwan is relatively lower 
than that in other countries with tropi-
cal or subtropical climates. Our study 
does not conclusively document the 
reason for lower incidence, although 
it does suggest an association between 
amount of rainfall and incidence. An 
understanding of the relationship be-
tween leptospirosis incidence and rain-
fall is indispensable for implementing 
appropriate preventive measures.
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Leishmania 
(Leishmania) 
amazonenis 
Infection, Suriname 
To the Editor: A 17-year-old man 
was seen at the Dermatology Service 
in Paramaribo (Suriname) with a skin 
condition that he had had since he was 
5 years of age. The condition consist-
ed of multiple cutaneous ulcerations, 
nodules, and ﬁ  brotic plaques dissemi-
nated on his face, limbs, and trunk, 
and subcutaneous nodules on lymph-
draining tracts on his hands, arms, and 
legs (online Appendix Figure, panel 
A, available from www.cdc.gov/EID/
content/14/5/857-appG.htm). He had 
lived his entire life in an inland village, 
located at Brokopondo Lake (central-
eastern Suriname); he had never trav-
eled outside the country. The diagno-
sis of cutaneous leishmaniasis (CL, a 
parasitic disease caused by the proto-
zoa Leishmania) was presumed. The 
patient received pentamidine therapy 
in 1997, 1998, and 2005, but without 
sustained clinical effect. Rapid screen-
ing tests for HIV were negative (De-
termine [Abbott Laboratories, Tokyo, 
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Figure. Leptospirosis cases (N = 291) in Taiwan, 2001–2006. A) Distribution by age and 
sex. B) Relationship between rainfall and leptospirosis incidence. Data represent averages 
for each month during the 6 years. LETTERS
Japan] and Unigold [Trinity Biotech, 
Co. Wicklow, Ireland]). In 2006, the 
diagnosis of CL was conﬁ  rmed with 
histopathology, culture, and PCR. 
The parasite was identiﬁ  ed by a PCR 
restriction fragment length polymor-
phism method on the small subunit–
internal transcribed spacer genes (1) 
and by multilocus enzyme electropho-
resis at the National Reference Center 
of Leishmania (Montpellier, France).
After promising results were ob-
tained with miltefosine in a patient with 
anergic diffuse cutaneous leishmaniasis 
(ADCL) in Venezuela (2), the patient 
received 150 mg/day oral miltefosine 
(Impavido, Zentaris, Germany) for 98 
days and the lesional parasite load was 
quantiﬁ   ed with quantitative nucleic 
acid sequence-based ampliﬁ  cation (3). 
Skin biopsy specimens were collected 
from 1 target lesion before treatment; 
during treatment at day 14, day 28, 
day 42 (all in duplicate); and at day 70 
(single biopsy).
The strain causing infection 
(MHOM/SR/2006/SP100) was iden-
tiﬁ  ed  as  Leishmania (Leishmania) 
amazonensis, and the enzymatic pro-
ﬁ  le was equal to L. (L.) amazonensis 
zymodeme MON-41. Histopathology 
showed large macrophages contain-
ing abundant Leishmania amastigotes 
and few lymphocytes and plasma cells 
without granuloma formation. A con-
siderable clinical improvement was 
observed during the ﬁ  rst 2 months of 
therapy. The lesions slowly decreased 
in size and duration. At day 70, all ul-
cerative lesions were re-epithelialized, 
without signs of inﬁ  ltration or lymp-
hangitis (online Appendix Figure, 
panel B). At start of treatment, parasite 
counts of 360,000 and 310,000 para-
sites per biopsy were detected; these 
counts decreased to 0 parasites/biopsy 
at day 70. Histopathologic studies at 
day 70 showed no Leishmania bodies, 
a dense lymphocytic and plasma cellu-
lar inﬁ  ltrate, and ﬁ  brosis. Apart from 
mild elevation of creatine and urea 
during treatment, no subjective or ad-
verse side effects were reported.
L. (L.) amazonensis causes CL and 
2 very serious manifestations of CL, 
disseminated cutaneous leishmaniasis 
(DCL) and ADCL (4). Both forms are 
histopathologically characterized by 
heavily parasitized macrophages and 
an absence of cell-mediated immune 
responses in therapy-naive patients 
(4). ADCL is resistant to any form of 
therapy, and cell-mediated immune 
responses never seem to occur. In 
contrast, the cell-mediated immune 
response in DCL can eventually arise 
upon therapy response, even in patients 
with previous therapy failures (4). The 
therapy response in DCL patients is 
histopathologically characterized by 
the appearance of a lymphocytic and 
plasma cellular inﬁ  ltrate. The diagno-
sis of DCL is plausible in our patient 
based on the histopathologic ﬁ  ndings 
before, during, and after therapy; the 
clinical picture (erythematous inﬁ  l-
trated plaques, lymphadenitis, and 
lymphangitis), and the favorable 
therapy response. He was last seen 7 
months after end of therapy, at which 
time new lesions had not developed.
In general, L. (L.) amazonensis in-
fection is rare in humans (5). In French 
Guiana, bordering the eastern side of 
Suriname, few patients (≈1.9%) are 
reported to be infected with this spe-
cies (5). However, the sandﬂ  y vector 
of  L. (L.) amazonensis,  Lutzomyia 
ﬂ  aviscutellata, was detected earlier 
in Suriname (6), which may indicate 
transmission of L. (L.) amazonensis 
infection to humans by means of the 
bite of this sandﬂ  y in Suriname. Our 
patient had no history of transfusion or 
intravenous drug use.
Many gold diggers from the north-
ern part of Brazil work and travel in 
Suriname and are familiar with CL. In 
the Brazilian State Pará, a region bor-
dering Suriname in the South, the in-
fection rate with L. (L.) amazonensis is 
high (34.8%) (7). It is thus conceivable 
that infected gold diggers from that 
area have introduced L. (L.) amazonen-
sis into Suriname. Our patient used to 
live in a village where many Brazilian 
gold diggers worked around the time 
that his skin lesions developed. Migra-
tion of laborers is associated with an 
increased risk for CL infection (8). The 
zymodeme MON-41 is widespread 
in Central America and the northern 
part of South America, and has been 
reported in Venezuela, Brazil, Pana-
ma, French Guiana, and Colombia (F. 
Pratlong and J.P. Dedet, Montpellier 
International Cryobank of Leishmania, 
pers. comm., 2007). Therefore, specu-
lations on the exact origin of the infec-
tion need to be made cautiously.
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Household 
Transmission of 
Carbapenemase-
producing 
Klebsiella 
pneumoniae 
To the Editor: Since its ﬁ  rst 
description in 2001, carbapenemase-
producing Klebsiella pneumoniae has 
become a frequent nosocomial patho-
gen in the eastern United States (1). 
This bacterium was introduced into 
Israel in 2005 and is endemic now in 
several hospitals in the country (2). 
We recently documented transmission 
of this organism within a household, 
the source being a debilitated patient 
who returned home after a long hos-
pitalization.
A 73-year-old man had a urologic 
procedure (transurethral resection of 
the bladder neck) in a community hos-
pital in early October 2007. He was 
initially evaluated on September 23, 
2007, at an outpatient clinic where a 
routine urine sample was obtained for 
culture. Carbapenemase-producing K. 
pneumoniae was cultured. Identiﬁ  ca-
tion and susceptibility testing of the 
isolate were completed by using the 
VITEK 2 system (bioMérieux, Marcy 
l’Etoile, France). K. pneumoniae car-
bapenemase was conﬁ  rmed by using 
the modiﬁ  ed Hodge test (3). Two re-
peat urine cultures grew the same or-
ganism; however, a stool culture was 
negative for carbapenemase-produc-
ing K. pneumoniae. 
The medical history of the patient 
included hypertension and carcinoma 
of the prostate gland that was treated 
with high-intensity focused ultrasound 
in May 2007, followed by transurethral 
resection of prostate in June 2007. The 
2 procedures were performed in 2 dif-
ferent private hospitals, and each re-
quired a 24-hour hospitalization. No 
carbapenemase-producing  K.  pneu-
moniae was documented in these hos-
pitals. Two months before detection 
of carbapenemase-producing K. pneu-
moniae, the patient received a 1-week 
course of oral amoxicillin-clavulanate 
for presumed urinary tract infection, 
although urine culture obtained on 
July 29, 2007 was sterile. A repeat 
urine culture 2 weeks later (August 
13, 2007) remained sterile.
Because the circumstances of 
strain acquisition and patient charac-
teristics were not typical for epidemi-
ology of carbapenemase-producing 
K.  pneumoniae ( 3), he was further 
questioned about possible contacts of 
relevance. The patient disclosed that 
his wife, who had amyotrophic lat-
eral sclerosis that required mechani-
cal ventilation, had been hospitalized 
in a tertiary hospital in the Tel Aviv 
area for 9 weeks until July 19, 2007. 
After discharge, she has been staying 
at home where she was cared for by 
her son, sister, and nurses; the patient 
stated that he had limited contact with 
his wife (he did not participate in her 
care). The infection control unit of 
the tertiary hospital was contacted, 
and the name of the wife was iden-
tiﬁ   ed in the hospital registry. Car-
bapenemase-producing  K.  pneumo-
niae was isolated from her urine on 
June 8, 2007.
Despite limited contact, the pa-
tient probably acquired carbapene-
mase-producing K. pneumoniae from 
his wife, who was a documented car-
rier of this organism. Because his ear-
ly urine cultures (taken after his wife 
was discharged from hospital) were 
sterile, we can assume that the trans-
mission of the organism occurred at 
their home. We cannot rule out that the 
strain was transferred by an intermedi-
ary, such as the couple’s son. It is un-
likely that the organism was acquired 
at the private hospitals from which no 
case of carbapenemase-producing K. 
pneumoniae was reported (in Israel re-
porting carbapenemase-producing K. 
pneumoniae isolates to health authori-
ties is mandatory). Also, the patient 
had 2 negative urine cultures.
Carbapenemase-producing  K. 
pneumoniae is a recent addition to the 
pool of multidrug-resistant nosoco-
mial pathogens. Most publications on 
this organism have focused on issues 
of structural and molecular epidemi-
ology. Little is known regarding clin-
ical characteristics and importance of 
infection with this organism. Until 
now, the strain has been recovered 
only from hospitalized patients with a 
longer hospital stay, those given mul-
tiple antimicrobial drug courses, and 
those mechanically ventilated (3,4). 
The strain can colonize the urinary, 
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